{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:58:59Z","timestamp":1779249539311,"version":"3.51.4"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.anndiagpath.2020.151623","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T01:41:19Z","timestamp":1599961279000},"page":"151623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["American Registry of Pathology Expert Opinions: Recommendations for the diagnostic workup of mature T cell neoplasms"],"prefix":"10.1016","volume":"49","author":[{"given":"Francisco","family":"Vega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina","family":"Amador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Chadburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2020.151623_bb0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/PAP.0000000000000047","article-title":"Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous","volume":"22","author":"Xing","year":"2015","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0010","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edn","first-page":"413","article-title":"Anaplastic large cell lymphoma, ALK-positive","author":"Falini","year":"2017"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0015","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edn","first-page":"418","article-title":"Anaplastic large cell lymphoma, ALK-negative","author":"Feldman","year":"2017"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0020","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edn","first-page":"392","article-title":"Primary cutaneous CD30-positive T-cell lymphoproliferative disorders","author":"Willemze","year":"2017"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0025","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edn","first-page":"421","article-title":"Breast implant-associated anaplastic large cell lymphoma","author":"Feldman","year":"2017"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0030","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/cup.12797","article-title":"Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding","volume":"43","author":"Al-Rohil","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0035","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","article-title":"ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion","volume":"32","author":"Chang","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0040","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/modpathol.2010.4","article-title":"PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus","volume":"23","author":"Feldman","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0045","first-page":"798","article-title":"Cytokeratin positivity in anaplastic large cell lymphoma: a potential diagnostic pitfall in misdiagnosis of metastatic carcinoma","volume":"6","author":"Zhang","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0050","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1309\/PLN1NA4QB2PC1CMQ","article-title":"The expression of myeloid antigens CD13 and\/or CD33 is a marker of ALK+ anaplastic large cell lymphomas","volume":"130","author":"Bovio","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0055","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0060","series-title":"T-cell lymphomas. NCCN clinical practice guidelines in oncology national comprehensive Cancer network","year":"2017"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0065","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/his.14005","article-title":"Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testing","volume":"76","author":"Peterson","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0070","article-title":"The importance of differentiating between mycosis fungoides with CD30 positive large cell transformation and mycosis fungoides with co-existent primary cutaneous anaplastic large cell lymphoma","author":"Gao","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/DAD.0000000000000717","article-title":"ALK expression is a rare finding in mycosis fungoides","volume":"39","author":"Covington","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0085","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. Vol revised 4th ed","year":"2017"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.leu.2404467","article-title":"Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 concerted action BHM4-CT98-3936","volume":"21","author":"van Krieken","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0095","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International peripheral T-cell lymphoma project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0100","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/PAS.0b013e31817d7452","article-title":"CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature","volume":"32","author":"Rahemtullah","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0105","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1182\/blood-2013-12-542142","article-title":"Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin","volume":"123","author":"Horwitz","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0110","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0115","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0120","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/PAS.0000000000000694","article-title":"A clinicopathologic study of Lennert lymphoma and possible prognostic factors: the importance of follicular helper T-cell markers and the association with angioimmunoblastic T-cell lymphoma","volume":"40","author":"Kurita","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000555","article-title":"Angioimmunoblastic T-cell lymphomas with the RHOA p.Gly17Val mutation have classic clinical and pathologic features","volume":"40","author":"Ondrejka","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0130","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/PAS.0b013e318268d9ff","article-title":"Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics","volume":"36","author":"Moroch","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0140","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.humpath.2012.05.002","article-title":"Follicular T-cell lymphoma: a member of an emerging family of follicular helper T-cell derived T-cell lymphomas","volume":"43","author":"Hu","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0150","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2559.2011.03981.x","article-title":"Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert\u2019s personal archive","volume":"59","author":"Agostinelli","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0155","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0160","doi-asserted-by":"crossref","first-page":"16124","DOI":"10.18632\/oncotarget.24592","article-title":"Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features","volume":"9","author":"Manso","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0165","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000001315","article-title":"Application of a 5 marker panel to the routine diagnosis of peripheral T-cell lymphoma with T-follicular helper phenotype","volume":"43","author":"Basha","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pathol.2019.08.013","article-title":"Diffuse large B-cell lymphoma variants: an update","volume":"52","author":"Sukswai","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0175","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/ajcp\/aqx034","article-title":"Predominance of CD4+ T cells in T-cell\/histiocyte-rich large B-cell lymphoma and identification of a subset of patients with peripheral B-cell lymphopenia","volume":"147","author":"Kunder","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0180","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/PAS.0000000000001414","article-title":"Expansion of PD1-positive T cells in nodal marginal zone lymphoma: a potential diagnostic pitfall","volume":"44","author":"Egan","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.12788\/j.sder.2018.005","article-title":"Sezary syndrome-clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Spicknall","year":"2018","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0190","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1523-1747.ep12388985","article-title":"Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile","volume":"103","author":"Saed","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0200","article-title":"Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides\/Sezary syndrome than quantification of CD26- or CD7- CD4+ T-cells","author":"Lyapichev","year":"2020","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0210","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/his.13463","article-title":"Aggressive natural killer (NK)-cell leukaemia and extranodal NK\/T-cell lymphoma are two distinct diseases that differ in their clinical presentation and cytogenetic findings","volume":"72","author":"Yang","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0215","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center","volume":"37","author":"Li","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens7010028","article-title":"EBV-positive lymphoproliferations of B- T- and NK-cell derivation in non-immunocompromised hosts","volume":"7","author":"Dojcinov","year":"2018","journal-title":"Pathogens"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0235","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071931","article-title":"The genomics and molecular biology of natural killer\/T-cell lymphoma: opportunities for translation","volume":"19","author":"de Mel","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0245","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","article-title":"Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm","volume":"89","author":"Chan","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0250","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41379-019-0415-5","article-title":"Mutational profile and EBV strains of extranodal NK\/T-cell lymphoma, nasal type in Latin America","volume":"33","author":"Montes-Mojarro","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0255","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1111\/j.1349-7006.2009.01319.x","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: new staging system and treatment strategies","volume":"100","author":"Kim","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0260","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0265","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0270","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imr.12248","article-title":"Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications","volume":"263","author":"Inghirami","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1525-1578(10)60610-1","article-title":"Hepatosplenic and subcutaneous panniculitis-like gamma\/delta T cell lymphomas are derived from different Vdelta subsets of gamma\/delta T lymphocytes","volume":"2","author":"Przybylski","year":"2000","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humpath.2018.01.005","article-title":"Hepatosplenic T-cell lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors","volume":"74","author":"Yabe","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0285","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","article-title":"Gamma-delta T-cell lymphomas","volume":"6","author":"Tripodo","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0290","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0295","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0300","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anndiagpath.2016.10.005","article-title":"Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-alpha inhibitor therapy and literature review","volume":"26","author":"Yabe","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0305","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.clml.2015.11.019","article-title":"Hepatosplenic T-cell lymphoma mimicking acute myeloid leukemia","volume":"16","author":"Pizzi","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0310","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","article-title":"Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases","volume":"40","author":"Yabe","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0315","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PAS.0000000000000743","article-title":"Distinguishing between hepatosplenic T-cell lymphoma and gammadelta T-cell large granular lymphocytic leukemia: a clinicopathologic, immunophenotypic, and molecular analysis","volume":"41","author":"Yabe","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0320","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1309\/AJCPTFFQ18JMYKDF","article-title":"Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-\/CD8-gammadelta T-cell large granular lymphocytic leukemia","volume":"136","author":"Chen","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0325","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.leu.2404112","article-title":"TCRgammadelta+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta+ T-cells","volume":"20","author":"Sandberg","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2007.04.011","article-title":"Clinical spectrum of gammadelta+ T cell LGL leukemia: analysis of 20 cases","volume":"32","author":"Bourgault-Rouxel","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175670","article-title":"Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRgammadelta+ T cell large granular lymphocyte leukemia","volume":"12","author":"Kallemeijn","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0340","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00277-013-1958-z","article-title":"Large granular lymphocytic leukemia of gamma-delta T cells: cytogenetics and fluorescence in situ hybridization study","volume":"93","author":"Ma","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0345","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ejh.12313","article-title":"Transformed aggressive gammadelta-variant T-cell large granular lymphocytic leukemia with acquired copy neutral loss of heterozygosity at 17q11.2q25.3 and additional aberrations","volume":"93","author":"Zhang","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0350","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jclinpath-2019-206255","article-title":"Causes of double-negative T-cell lymphocytosis in children and adults","volume":"73","author":"Liapis","year":"2020","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0355","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0360","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.beha.2019.06.003","article-title":"Genomics of LGL leukemia and select other rare leukemia\/lymphomas","volume":"32","author":"Moosic","year":"2019","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0365","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition)","first-page":"2017","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0370","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00000478-200604000-00017","article-title":"Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease","volume":"30","author":"Vega","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0375","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","article-title":"NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series","volume":"117","author":"Mansoor","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0380","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","article-title":"The Oslo definitions for coeliac disease and related terms","volume":"62","author":"Ludvigsson","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0385","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s10875-014-0075-7","article-title":"Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease","volume":"34","author":"van Wanrooij","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0390","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/gut.51.3.372","article-title":"Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression","volume":"51","author":"Farstad","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0395","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00428-019-02704-8","article-title":"Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas","volume":"476","author":"Montes-Moreno","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0400","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","article-title":"Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study","volume":"45","author":"Malamut","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0405","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/leu.2010.295","article-title":"Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma","volume":"25","author":"Tan","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0410","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/modpathol.2017.145","article-title":"SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"31","author":"Mutzbauer","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0415","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","article-title":"Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype","volume":"27","author":"Tan","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0420","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0000000000000296","article-title":"Profile of CD103 expression in T-cell neoplasms: immunoreactivity is not restricted to enteropathy-associated T-cell lymphoma","volume":"38","author":"Morgan","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0425","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PAS.0000000000000597","article-title":"High expression of intestinal homing receptor CD103 in adult T-cell leukemia\/lymphoma, similar to 2 other CD8+ T-cell lymphomas","volume":"40","author":"Ishibashi","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0430","article-title":"Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract","author":"Soderquist","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0435","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","article-title":"Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma","volume":"161","author":"Zettl","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0440","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20160894","article-title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","volume":"214","author":"Moffitt","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0445","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2016.07.018","article-title":"Interleukin-15-dependent T-cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease","volume":"45","author":"Ettersperger","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0450","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12602","article-title":"Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations","volume":"7","author":"Roberti","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0455","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1066896918785985","article-title":"Disease progression in a patient with indolent T-cell lymphoproliferative disease of the gastrointestinal tract","volume":"27","author":"Perry","year":"2019","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068343","article-title":"Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features","volume":"8","author":"Margolskee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0465","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/modpathol.2013.120","article-title":"Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study","volume":"27","author":"Mollejo","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0470","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.humpath.2013.08.003","article-title":"Indolent peripheral T-cell lymphoma involving the gastrointestinal tract","volume":"45","author":"Leventaki","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0475","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1182\/blood-2010-06-290650","article-title":"Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation","volume":"116","author":"Takeuchi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0480","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2018-01-830968","article-title":"Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract","volume":"131","author":"Sharma","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151623_bb0485","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood.2019001443","article-title":"Recurrent somatic JAK3 mutations in NK-cell enteropathy","volume":"134","author":"Xiao","year":"2019","journal-title":"Blood"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:33:03Z","timestamp":1761078783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420301696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":97,"alternative-id":["S1092913420301696"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151623","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Registry of Pathology Expert Opinions: Recommendations for the diagnostic workup of mature T cell neoplasms","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151623"}}